血管黏附蛋白-1通过生成过氧化氢增强肾缺血再灌注损伤中的中性粒细胞浸润
研究在大鼠肾缺血再灌注损伤模型中观察血管黏附蛋白-1(VAP-1)的表达及其抑制作用。VAP-1主要表达于周细胞并释放有酶活性的酶;特异性抑制剂RTU-1096显著减轻大鼠肾缺血再灌注损伤,并在损伤后12小时减少中性粒细胞浸润,而不改变巨噬细胞或T淋巴细胞群。
要点
- VAP-1主要表达于周细胞并释放有酶活性的酶。
- RTU-1096显著减轻大鼠肾缺血再灌注损伤并减少12小时中性粒细胞浸润。
- VAP-1抑制的保护作用在去中性粒细胞大鼠中消失。
核心结论
- VAP-1通过生成局部过氧化氢梯度增强中性粒细胞浸润,在肾缺血再灌注损伤病理生理中起关键作用。
- 作者认为VAP-1抑制可能是缺血性急性肾损伤的一种新疗法。
研究设计与样本
- 研究在大鼠肾缺血再灌注损伤模型中观察VAP-1表达及抑制效果。
- 体外采用纯化人中性粒细胞进行琼脂糖下迁移实验。
主要发现
- VAP-1主要表达于周细胞,周细胞释放有酶活性的酶。
- 特异性VAP-1抑制剂RTU-1096显著减轻大鼠肾缺血再灌注损伤,并减少损伤后12小时中性粒细胞浸润,而不改变巨噬细胞或T淋巴细胞群。
- VAP-1抑制的保护作用在去中性粒细胞大鼠中消失。
- 重组人VAP-1显著诱导中性粒细胞迁移,该迁移几乎完全被RTU-1096或过氧化氢酶抑制。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vascular adhesion protein-1 (VAP-1) is a unique molecule since it acts as an adhesion molecule as well as an ectoenzyme catalyzing oxidative deamination of primary amines and generates hydrogen peroxide in the extracellular space. While VAP-1 is implicated in various inflammatory diseases, its role in acute kidney injury is less characterized. Here we studied VAP-1 expression in the kidney and the effect of its inhibition in a rat model of renal ischemia/reperfusion injury. VAP-1 was predominantly expressed in pericytes, which released enzymatically active enzyme. In vivo, a specific VAP-1 inhibitor, RTU-1096, significantly ameliorated rat renal ischemia/reperfusion injury and decreased neutrophil infiltration measured 12 hours after injury without altering macrophage or T lymphocyte populations. The protective effect of VAP-1 inhibition was lost in neutrophil-depleted rats, suggesting its inhibition ameliorated renal ischemia/reperfusion injury by suppressing neutrophil infiltration. To investigate whether hydrogen peroxide generated by VAP-1 enzyme reaction enhances neutrophil infiltration, we conducted an under-agarose migration assay with purified human neutrophils. Recombinant human VAP-1 significantly induced neutrophil migration, which was almost completely inhibited by RTU-1096 or catalase. Thus, VAP-1 plays a critical role in the pathophysiology of renal ischemia/reperfusion injury by enhancement of neutrophil infiltration generating a local hydrogen peroxide gradient. Hence, VAP-1 inhibition may be a novel therapy in ischemic acute kidney injury.
引用
- Tanaka S, Tanaka T, Kawakami T, et al. Vascular adhesion protein-1 enhances neutrophil infiltration by generation of hydrogen peroxide in renal ischemia/reperfusion injury. Kidney Int. 2017. PMID: 28318627. doi:10.1016/j.kint.2017.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。